Invicta Diagnostic IPO Financials
The Invicta Diagnostic IPO provide an overview of the company's performance over the previous financial periods. Investors can evaluate key financial metrics such as assets, revenue, profit after tax (PAT), net worth, reserves & surplus, and total borrowings to assess the company's financial strength, profitability, and long-term growth potential before investing in the IPO.
As of 31 Mar 2025, Invicta Diagnostic Limited reported assets of ₹21.22 crore, revenue of ₹30.18 crore, and a profit after tax (PAT) of ₹4.93 crore. The company had a net worth of ₹13.6 crore and reserves & surplus of ₹5.18 crore, and total borrowings are 3.54 crore.
Revenue decreased by 47.32% in 31 Mar 2024, while Profit After Tax (PAT) declined by 22.72% in 31 Mar 2024, respectively.
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Invicta Diagnostic Limited Financials (₹ in Crores)
| Particular | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|
| Assets | 21.22 | 15.89 |
| Revenue | 30.18 | 15.9 |
| Profit After Tax | 4.93 | 3.81 |
| Net Worth | 13.6 | 8.67 |
| Reserve & Surplus | 5.18 | 8.54 |
| Total Borrowings | 3.54 | 3.81 |
EPS Pre
5.32%
EPS Post
3.92%
P/E Pre
15.97
P/E (Post Issue)
21.68x
Company Financial Information
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Revenue of Invicta Diagnostic Limited ?
Invicta Diagnostic Limited reported revenue of ₹30.18 crore as of 31 Mar 2025. Revenue figures from the Invicta Diagnostic IPO provide insights into sales growth, market demand, and business scalability.
What is the Profit After Tax (PAT) of Invicta Diagnostic Limited ?
Invicta Diagnostic Limited reported a Profit After Tax (PAT) of ₹4.93 crore as of 31 Mar 2025. PAT represents the company's net profit after deducting all operating expenses, interest, taxes, and other applicable charges, making it a key indicator of overall profitability.
What is the PE Ratio of Invicta Diagnostic Limited ?
Invicta Diagnostic Limited has a Price-to-Earnings (P/E) ratio of 15.97x based on the IPO issue price. The P/E ratio compares the company's share price with its earnings per share (EPS) and is a commonly used valuation metric to assess whether a stock is fairly valued relative to its earnings and industry peers.